Edmond M Kwan Selected Research

Edmond M Kwan Research Topics

38	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2018
11	Neoplasms (Cancer) 01/2024 - 02/2019
3	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2023
1	Pain (Aches) 12/2021
1	Adenocarcinoma 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2019
1	Brain Neoplasms (Brain Tumor) 10/2019
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2017
1	Pneumonia (Pneumonitis) 09/2017

11	Androgen Receptors (Androgen Receptor)IBA 02/2023 - 01/2018
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
7	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2020
6	AntigensIBA 11/2023 - 01/2021
6	Hormones (Hormone)IBA 01/2023 - 01/2020
5	Circulating Tumor DNAIBA 01/2024 - 01/2020
4	Prostate-Specific Antigen (Semenogelase)IBA 11/2023 - 04/2021
4	enzalutamideIBA 01/2023 - 01/2018
4	Cell-Free Nucleic AcidsIBA 11/2021 - 02/2019
3	cabazitaxel FDA Link 11/2023 - 01/2021
3	abirateroneIBA 01/2023 - 01/2018
3	LipidsIBA 01/2023 - 10/2021
2	Lutetium-177IBA 11/2023 - 01/2021
2	Docetaxel (Taxotere)FDA Link 11/2023 - 01/2020
2	taxaneIBA 01/2022 - 11/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
2	AndrogensIBA 04/2020 - 01/2018
1	Taxoids (Taxanes)IBA 02/2023
1	Immune Checkpoint InhibitorsIBA 03/2022
1	IceIBA 03/2022
1	avelumabIBA 03/2022
1	NivolumabIBA 01/2022
1	Radioisotopes (Radionuclides)IBA 01/2022
1	177Lu-PSMA-617IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	SphingolipidsIBA 01/2022
1	rucaparibIBA 01/2022
1	Aligeron (AS 2)IBA 01/2022
1	LutetiumIBA 12/2021
1	CytokinesIBA 10/2021
1	sphingosine kinaseIBA 10/2021
1	3- (4- chlorophenyl)- adamantane- 1- carboxylic acid (pyridin-4-ylmethyl)amideIBA 10/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Abiraterone AcetateIBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 09/2017